← Browse by Condition
Medical Condition

obstructive sleep apnea

Total Trials
17
Recruiting Now
17
Trial Phases
Phase 1, Phase 2, Phase 2

ClinicalMetric tracks all active clinical trials for obstructive sleep apnea sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — obstructive sleep apnea Clinical Trials

How many clinical trials are currently recruiting for obstructive sleep apnea?
ClinicalMetric currently tracks 17 actively recruiting clinical trials for obstructive sleep apnea, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 17. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for obstructive sleep apnea?
obstructive sleep apnea research spans Phase 1 (2 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a obstructive sleep apnea clinical trial?
Eligibility criteria for obstructive sleep apnea trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
3
Top Sponsors
Brigham and Women's Hospital 2 trials
Chinese University of Hong Kong 2 trials
Michael Harrison 1 trial
National University of Malaysia 1 trial
University of Sao Paulo General Hospital 1 trial

Recruiting Clinical Trials

NCT02431507
Recruiting
Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety
Enrollment
10 pts
Location
United States
Sponsor
Michael Harrison
View Trial →
NCT03858751 Phase 1, Phase 2
Recruiting
Pharmacological Activation of HMN for OSA Aim 2
Enrollment
16 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT06564896
Recruiting
Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM)
Enrollment
50 pts
Location
Malaysia
Sponsor
National University of Malaysi...
View Trial →
NCT06570629
Recruiting
Addressing Unintentional Leakage When Using Nasal CPAP - Study B
Enrollment
50 pts
Location
Brazil
Sponsor
University of Sao Paulo Genera...
View Trial →
NCT06258837
Recruiting
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
Enrollment
175 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
View Trial →
NCT06803095
Recruiting
Efficacy of Walking Exercise With Dog on Tinnitus Complaints in Sleep Apnea (Obstructive Sleep Apnea)
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT06239883
Recruiting
This Research Project Studies the Relationship Between OSA and Nocturia.
Enrollment
100 pts
Location
Czechia
Sponsor
University Hospital Ostrava
View Trial →
NCT03725956
Recruiting
Polysomnographic Findings in Nasal Polyposis
Enrollment
30 pts
Location
France
Sponsor
University Hospital, Lille
View Trial →
NCT05804084 Phase 2
Recruiting
Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea
Enrollment
60 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT05050383
Recruiting
DISE: Phenotyping Obstruction Patterns
Enrollment
241 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT04658290
Recruiting
Prevalence of Obstructive Sleep Apnea (OSA) and the Association With Cognitive Impairment
Enrollment
500 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT05350215 Phase 1, Phase 2
Recruiting
Atomoxetine and DAW2022 on OSA Severity
Enrollment
18 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT04124848
Recruiting
Obstructive Sleep Apnea Among Somali-Americans
Enrollment
600 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06664450
Recruiting
Brain Fog in Sleep Apnea
Enrollment
80 pts
Location
Italy
Sponsor
Fondazione Don Carlo Gnocchi E...
View Trial →
NCT07111962
Recruiting
Effectiveness of NOA OATMAD
Enrollment
150 pts
Location
Canada
Sponsor
University of Alberta
View Trial →
NCT06522815
Recruiting
Updating Deep Learning Algorithms for OSA Monitoring
Enrollment
107 pts
Location
South Korea
Sponsor
Sky Labs
View Trial →
NCT06453018
Recruiting
Positional Therapy for Childhood Obstructive Sleep Apnoea
Enrollment
20 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →

Related Conditions

continuous positive airway pressure (1) adverse effect (1) otolaryngological disease (1) tinnitus subjective (1) chronic rhinosinusitis with nasal polyps (1) cognitive impairment (1) obstructive sleep apnea hypopnea (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology